数字乳腺断层融合X线成像(DBT)对乳腺病变的诊断价值
研究纳入250例患者共253个经病理证实的乳腺病灶,术前分别用FFDM、DBT及两者联合独立诊断。DBT与联合诊断的ROC曲线下面积均大于FFDM,在乳腺密度>50%、年龄≤50岁、未绝经、非原位癌及病灶长径>10 mm且≤20 mm时DBT诊断更具优势,DBT显示病灶最长径与病理测量值相关性更高。
要点
- DBT诊断乳腺病变的ROC曲线下面积为0.890,大于FFDM的0.833。
- 乳腺密度>50%、年龄≤50岁、未绝经者中DBT诊断效能优于FFDM。
- 非原位癌中DBT敏感度92.3%(120/130)高于FFDM的83.8%(109/130)。
核心结论
- 与FFDM相比,DBT在乳腺密度>50%、年龄≤50岁、未绝经、非原位癌和10 mm<癌灶长径≤20 mm的患者中诊断乳腺癌更具优势,且DBT显示乳腺癌病灶最长径更准确。
研究设计与样本
- 选择经病理证实的253个乳腺病灶,术前分别采用FFDM、DBT、DBT联合FFDM进行独立诊断,以病理诊断为金标准。
主要发现
- DBT、FFDM和两者联合诊断乳腺病变的ROC曲线下面积分别为0.890、0.833和0.890,DBT及联合诊断均大于FFDM(均P<0.05)。
- 在乳腺密度>50%、年龄≤50岁和未绝经组中,DBT及联合诊断的ROC曲线下面积大于FFDM(P<0.05);在乳腺密度≤50%、年龄>50岁和已绝经组中差异无统计学意义(P>0.05)。
- DBT和FFDM在原位癌中的敏感度均为90.9%(10/11),在非原位癌中的敏感度分别为92.3%(120/130)和83.8%(109/130)。
- 在病灶≤10 mm、10 mm<病灶≤20 mm、20 mm<病灶≤30 mm、30 mm<病灶≤40 mm组中,DBT敏感度分别为51.7%(4/7)、93.8%(61/65)、96.7%(30/31)、100%(11/11),FFDM分别为51.7%(4/7)、78.5%(51/65)、93.5%(29/31)、100%(11/11)。
- DBT和FFDM显示乳腺癌病灶最长径与病理测量值的相关系数分别为0.905和0.849(P<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To assess the value of digital breast tomosynthesis (DBT) in the diagnosis of breast lesions. Methods: Two hundred and fifty-three breast lesions in 250 patients were selected in this study. All lesions were confirmed pathologically. Preoperative diagnosis was performed independently with full-field digital mammography (FFDM), DBT and DBT plus FFDM, respectively. The diagnostic value of DBT for breast lesions was evaluated based on the pathological diagnosis as the gold standard. The diagnostic performance of DBT and FFDM for breast lesions was compared between the groups with different ages, mammary gland densities and hormone levels. The sensitivity of DBT and FFDM was compared between the groups with different pathological types and different sizes of breast cancer. The correlation between the longest diameter of breast cancers and pathological measurements shown on DBT and FFDM was analyzed. Results: The areas under ROC curves were 0.890, 0.833 and 0.890 for DBT, FFDM and DBT plus FFDM, respectively. The areas under ROC curves for DBT or DBT plus FFDM were significantly greater than that for FFDM (P<0.05). In the group with breast density>50%, group with age ≤50 and non-menopause group, all the areas under ROC curves for DBT or DBT plus FFDM were all significantly larger than that for FFDM (P<0.05). No significant differences were observed in the group with breast density ≤50%, group with age>50 and menopause group (P>0.05). The sensitivity for both DBT and FFDM in the diagnosis of carcinoma in situ was 90.9% (10/11). The sensitivity for DBT and FFDM in the diagnosis of non-carcinoma in situ was 92.3% (120/130) and 83.8% (109/130), respectively. The sensitivity in the groups with the longest diameter of foci >0 mm but ≤10 mm, >10 mm but ≤20 mm, >20 mm but ≤30 mm, and >30 mm but ≤40 mm were 51.7% (4/7), 93.8% (61/65), 96.7% (30/31) and 100% (11/11), respectively, for DBT, and were 51.7% (4/7), 78.5% (51/65), 93.5% (29/31), and 100% (11/11), respectively, for FFDM. The correlation coefficients between the longest diameter of breast cancers and pathological measurements shown on DBT and FFDM were 0.905 and 0.849, respectively (P<0.001). Conclusions: Compared with FFDM, DBT shows a higher diagnostic efficiency in patients with breast density >50%, age ≤50 years and non-menopause, non-carcinoma in situ, and the longest diameter of lesions >10 mm but ≤ 20 mm. The longest diameter of breast lesions is more accurately shown on DBT. 目的: 评价数字乳腺断层融合X线成像(DBT)对乳腺病变的诊断价值。 方法: 选择经病理证实的253个乳腺病灶,术前分别采用全视野数字化乳腺摄影(FFDM)、DBT、DBT联合FFDM进行独立诊断,以病理诊断作为金标准,评价DBT对乳腺病变的诊断价值,比较DBT和FFDM在不同年龄、不同乳腺腺体密度和不同激素水平亚组中对乳腺病变的诊断效能,比较DBT和FFDM在不同病理类型乳腺癌和不同大小乳腺癌中的敏感度,比较DBT和FFDM显示乳腺癌病灶的最长径与病理测量值的相关性。 结果: DBT、FFDM和两者联合诊断乳腺病变的受试者工作特征(ROC)曲线下面积分别为0.890、0.833和0.890。DBT、DBT联合FFDM诊断乳腺病变的ROC曲线下面积均大于FFDM(均P<0.05)。 在乳腺密度>50%、年龄≤50岁和未绝经组中,DBT、DBT联合FFDM诊断乳腺病变的ROC曲线下面积大于FFDM(P<0.05);在乳腺密度≤50%、年龄>50岁和已绝经组中,DBT、DBT联合FFDM诊断乳腺病变的差异无统计学意义(P>0.05)。DBT和FFDM在原位癌中的敏感度均为90.9%(10/11),DBT和FFDM在非原位癌中的敏感度分别为92.3%(120/130)和83.8%(109/130)。在病灶≤10 mm、10 mm<病灶≤20 mm、20 mm<病灶≤30 mm、30 mm<病灶≤40 mm组中,DBT和FFDM诊断乳腺癌的敏感度分别为51.7%(4/7)和51.7%(4/7)、93.8%(61/65)和78.5%(51/65)、96.7%(30/31)和93.5%(29/31)、100%(11/11)和100%(11/11)。DBT和FFDM显示乳腺癌病灶最长径与病理测量值的相关系数分别为0.905和0.849(P<0.001)。 结论: 与FFDM相比,在乳腺密度>50%、年龄≤50岁、未绝经、非原位癌和10 mm<癌灶长径≤20 mm的患者中,DBT诊断乳腺癌更具优势,DBT显示乳腺癌病灶最长径更准确。.
引用
- Yang L, Li J, Zhou CW, et al. [Value of digital breast tomosynthesis (DBT) in the diagnosis of breast lesions]. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 28104031. doi:10.3760/cma.j.issn.0253-3766.2017.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。